Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC 2024-04-26 21:00
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers 2024-04-26 21:00
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa 2024-04-26 12:39
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints 2024-04-26 01:25
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor 2024-04-25 22:00
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil 2024-04-25 21:41
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer 2024-04-25 17:11
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono 2024-04-25 14:00
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST 2024-04-25 09:02
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint 2024-04-24 22:31
Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting 2024-04-24 22:10
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results 2024-04-24 19:00
Samsung Biologics Reports First Quarter 2024 Financial Results 2024-04-24 14:45
Yeast Fuel, Developed by Chula's Faculty of Science Soon to Expand Its Production for the Aerospace Industry 2024-04-24 00:00
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market 2024-04-23 18:37
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML) 2024-04-23 14:54
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing 2024-04-23 08:00
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024 2024-04-23 07:25
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial 2024-04-22 20:30
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer 2024-04-22 17:51
1 2 3 4 5 202